MOBILion Systems

Philadelphia, United States Founded: 2015 • Age: 11 yrs Acquired By Waters Corporation
Analytical mass spectrometry instruments for clinical diagnostics are manufactured.

About MOBILion Systems

MOBILion Systems is a Healthcare company based in Philadelphia (United States) founded in 2015, and was acquired by Waters Corporation in November 2026. Analytical mass spectrometry instruments for clinical diagnostics are manufactured. MOBILion Systems has raised $114.5 million across 7 funding rounds from investors including Agilent, Hostplus and Waters Corporation. The company has 2 employees. MOBILion Systems offers products and services including MOBIE Platform, Targeted Lipidomics Workflow, Peptide Characterization, and Glycan Analysis. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Imaging Systems. Its legal entity is MOBILION SYSTEMS, INC. Its competitors include 908 Devices, Advion and Impedimed; 3 of its 3 listed competitors have raised funding.

Company details

MOBILion Systems was founded in 2015 in Philadelphia, United States, and operates in the analytical mass spectrometry sector. Instruments for diagnostic and therapeutic applications in clinical environments are provided. SLIM technology is utilized for lossless ion transfer, manipulation, and mobility separations. Operations focus on enabling rapid analysis of biological samples and separation of biomolecules, with emphasis on sensitivity and resolution in clinical workflows.

Key Metrics
  • Total Equity Funding
    $114.5M (USD)

    in 7 rounds

  • Latest Funding Round
    $60M (USD), Series C

    Jul 2021

  • Investors
    Agilent

    & 8 more

  • Employee Count
    2
  • Acquired by
    Waters Corporation

    & 1 more

    (Nov 2026)

Products & Services of MOBILion Systems

MOBILion Systems offers a comprehensive portfolio of products and services, including MOBIE Platform, Targeted Lipidomics Workflow, Peptide Characterization, and Glycan Analysis.

MOBIE Platform
Analytical Instrument

Provides high-resolution separation for complex molecule analysis in research.

Targeted Lipidomics Workflow
Analysis Tool

Enables quick identification of lipid isomers in biological systems.

Peptide Characterization
Molecular Workflow

Facilitates definitive detection of peptide modifications for therapeutics.

Glycan Analysis
Biomarker Tool

Offers accurate isomer detection impacting product characteristics.

Funding Insights of MOBILion Systems

MOBILion Systems has successfully raised a total of $114.5M across 7 strategic funding rounds. The most recent funding activity was a Series C round of $60 million completed in July 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $114.5M
  • Total Rounds 7
  • Last Round Series C β€” $60M
  • First Round $4M

    (Apr 2019)

  • Investors Count 8

All 7 funding rounds of MOBILion Systems with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jul 2021$60MSeries C–Agilent
Dec 2020$100,000Grant––
Nov 2020Grant––
Aug 2020$35.1MSeries B–aMoon
May 2020$6MDebt – Conventional––
–
Nov 2019$15.4MSeries A–Agilent
Apr 2019$4MSeries A––
–
Valuation history

9 investors in total: 9 institutional.

Investors in MOBILion Systems

MOBILion Systems has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include Agilent, Hostplus and Waters Corporation.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Venture capital investments in healthcare are focused on by aMoon.
amoon.fund
Venture capital and advisory services are offered across multiple sectors.
2001ipgroupplc.comLondon, United Kingdom
Early-stage tech companies are funded by this venture capital firm.
cultivationcapital.comSt. Louis, United States
Early-stage investments are targeted by iSelect Fund in key sectors.
iselectfund.comSt. Louis, United States
Diversified instruments are developed for scientific and laboratory management.
1995agilent.comSanta Clara, United States
Pension funds are managed for Australian superannuation members.
1988hostplus.com.auMelbourne, Australia
nasa-science-challenge.com
Research for Parkinson's disease is funded by the foundation.
2000michaeljfox.orgNew York, United States
Provider of laboratory management system for researchers and clinicians
1958waters.comMilford, United States
Premium access

Investor details for MOBILion Systems

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of MOBILion Systems

33 people are tracked at MOBILion Systems (8 in leadership, 12 in board & advisors, 13 in team); the tracked headcount is 2.

NameRoleGroup
Katie Spruance
Senior Director, Talent & CultureLeadership
Daniel Debord
VP, R&DLeadership
Melissa Sherman
CEOLeadership
Craig Carra
CFOLeadership
Ed Cywinski
Senior Director of FinanceLeadership
Gregory Webster
VP, Product DevelopmentLeadership
Miriam Fico
Director Of Applications & New TechnologiesLeadership
Lujean Burak
Director Of QualityLeadership
Kevin Bateman
Advisory Board MemberBoard & advisors
Gustavo Salem
Advisory Board MemberBoard & advisors
Sally Curley
Advisory Board MemberBoard & advisors
Todd Sone
DirectorBoard & advisors
Tad Weems
DirectorBoard & advisors
Kaveh Kahen
Advisory Board MemberBoard & advisors
Ravinder Singh
Advisory Board MemberBoard & advisors
David Speicher
Advisory Board MemberBoard & advisors
Jenn Buechel
DirectorBoard & advisors
Tim Germann
AdvisorBoard & advisors
Jason Smith
DirectorBoard & advisors
Heiner Dreismann
Chairman, Board of DirectorsBoard & advisors

13 more people are available in the full profile.

Premium access

Complete people profiles for MOBILion Systems

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of MOBILion Systems

5 dated milestones of MOBILion Systems across 11 years, from founding to its latest funding, stage changes and deals.

  1. Founded MOBILion Systems is founded.
  2. Funding First funding round of $4.0M.
  3. Funding Latest funding round, Series C, of $60.0M.
  4. Exit Acquired by Waters Corporation.
  5. Exit Acquired by Waters Corporation.

Competitors of MOBILion Systems

MOBILion Systems has 3 listed competitors in our database, 3 of them funded. They include 908 Devices, Advion and Impedimed.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
908devices.com2012Boston, United States$68.22M93
Handheld chemical detection devices are manufactured using mass spectrometry.
advion.com1993Ithaca, United States$45.64M54
Microfluidics and mass spectrometry products are provided for clinical research.
impedimed.com1999Carlsbad, United States$3.44M76
Technologies for non-invasive fluid status assessment and monitoring are developed.
Premium access

Detailed competitors of MOBILion Systems

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of MOBILion Systems

The website of MOBILion Systems (mobilionsystems.com) receives about 2.9K visits a month.

  • Monthly visits
    2.9K

    ▲ 71.9% vs previous month

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as MOBILion Systems (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B1,111
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Mobilion Systems

Premium access

Complete news archive for MOBILion Systems

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about MOBILion Systems

MOBILion Systems was founded in 2015 and raised its 1st funding round 4 years after it was founded.

MOBILion Systems is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.

MOBILion Systems is a funded company, having raised a total of $114.5M across 7 funding rounds to date. The company's 1st funding round was a Series A of $4M, raised on Apr 2019.

MOBILion Systems has 2 employees.

MOBILion Systems was founded in 2015 in Philadelphia, United States, and operates in the analytical mass spectrometry sector. Instruments for diagnostic and therapeutic applications in clinical environments are provided. SLIM technology is utilized for lossless ion transfer, manipulation, and mobility separations. Operations focus on enabling rapid analysis of biological samples and separation of biomolecules, with emphasis on sensitivity and resolution in clinical workflows.

MOBILion Systems's top competitors include 908 Devices, Impedimed and Advion.

MOBILion Systems offers MOBIE Platform, Targeted Lipidomics Workflow, Peptide Characterization, and Glycan Analysis.

MOBILion Systems has 9 investors. Key investors include Agilent, Hostplus, Waters Corporation, IP Group, and The Michael J. Fox Foundation.

MOBILion Systems operates through Mobilion Systems, Inc..

Yes. MOBILion Systems was acquired by Waters Corporation in November 2026.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available